Clinical Trial Update: Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating concurrent nab-paclitaxel with intensity-modulated radiation therapy in patients with stage III-IVa nasopharyngeal carcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 1 | Status: RECRUITING